INVESTOR AB - CORCEPT THERAPEUTICS INC ownership

CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 96 filers reported holding CORCEPT THERAPEUTICS INC in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
INVESTOR AB ownership history of CORCEPT THERAPEUTICS INC
ValueSharesWeighting
Q3 2017$14,483,000
+63.6%
750,4230.0%0.93%
+50.4%
Q2 2017$8,855,000
+7.7%
750,4230.0%0.62%
+5.8%
Q1 2017$8,225,000
-17.6%
750,423
-45.4%
0.59%
-19.5%
Q4 2016$9,986,000
-16.3%
1,375,422
-25.1%
0.73%
-15.0%
Q3 2016$11,934,000
+19.1%
1,835,9740.0%0.86%
+14.7%
Q2 2016$10,024,000
+16.7%
1,835,9740.0%0.75%
+18.9%
Q1 2016$8,592,000
-5.8%
1,835,974
+0.2%
0.63%
-15.1%
Q4 2015$9,122,000
+32.5%
1,831,6800.0%0.74%
+20.9%
Q3 2015$6,887,000
-34.4%
1,831,680
+4.8%
0.61%
-37.7%
Q2 2015$10,501,000
-39.3%
1,747,320
-43.4%
0.98%
-36.4%
Q1 2015$17,301,000
+66.9%
3,089,505
-10.6%
1.55%
+54.1%
Q4 2014$10,364,000
+11.9%
3,454,7450.0%1.00%
+2.3%
Q3 2014$9,259,000
-4.3%
3,454,7450.0%0.98%
-10.7%
Q2 2014$9,673,000
-35.8%
3,454,7450.0%1.10%
-38.0%
Q1 2014$15,063,000
+35.8%
3,454,7450.0%1.77%
+38.0%
Q4 2013$11,090,000
+100.6%
3,454,7450.0%1.28%
+99.4%
Q3 2013$5,528,000
-7.5%
3,454,7450.0%0.64%
-8.8%
Q2 2013$5,977,0003,454,7450.70%
Other shareholders
CORCEPT THERAPEUTICS INC shareholders Q1 2016
NameSharesValueWeighting ↓
INGALLS & SNYDER LLC 8,340,193$227,22910.94%
Novo Holdings A/S 3,377,768$92,044,1786.80%
Parallel Advisors, LLC 3,723,483$101,446,2943.38%
TANAKA CAPITAL MANAGEMENT INC 37,569$1,0242.92%
S&T BANK/PA 334,252$9,1071.76%
Birchview Capital, LP 50,000$1,362,2501.16%
Granite Investment Partners, LLC 798,552$21,756,5490.91%
FAS Wealth Partners, Inc. 310,764$8,466,7660.90%
Clearview Wealth Advisors LLC 25,258$688,1550.85%
Bridge City Capital, LLC 43,485$1,184,7490.60%
View complete list of CORCEPT THERAPEUTICS INC shareholders